We make them accessible.
It’s also the science.
Blazing the Trail to European Exports: Panaxia Israel Announces Receipt of EU-GMP Certification, Required for the Manufacture and European Export of Medical Cannabis and Advanced Products
June 11, 2020 | Yahoo Finance Dr. Dadi Segal, CEO of Panaxia Global, said, “Receiving EU-GMP certification is a defining moment for us and for the
June 8, 2020 | Market Watch Dr. Dadi Segal, CEO of Panaxia Global, said, “Panaxia started 2020 with a strong quarter boasting expanded operations, record quarterly
April 10, 2020 | Reuters Specialty drugmaker Neuraxpharm has teamed up with Israel’s Panaxia Labs to market medical cannabis, saying it would be the first
APRIL 9, 2020 | Cannabis Law Report Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd. (TASE: PNAX), announced a contractual agreement to use
Panaxia Is Preparing for European Sales: Announces an Agreement for Temporary Use Rights in an R&D Facility in Malta for the Commercial Production and Marketing of Its European Cannabis Products in Europe
April 6, 2020 | Yahoo Finance Dr. Dadi Segal, Panaxia CEO: “Using the Malta facility is a significant stepping stone as we enter the European market. We believe
April 3, 2020 |Benzinga Medical cannabis producer Panaxia Labs Israel Ltd. (TASE:PNAX) has finalized a 17 million ILS ($4.67 million) private placement of common stock and warrants to Israeli institutional